N-Cbz-N-methyl-L-isoleucine

We are N-Cbz-N-methyl-L-isoleucine CAS:42417-66-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 42417-66-3
Product Name: N-Cbz-N-methyl-L-isoleucine
Other Name:
N-Cbz-N-methyl-L-isoleucine
N-[(Benzyloxy)carbonyl]-N-methyl-L-isoleucine
(2S,3S)-2-(((Benzyloxy)carbonyl)(methyl)amino)-3-methylpentanoic acid
 
Density: 1.1±0.1 g/cm3
Boiling Point: 419.4±34.0 °C at 760 mmHg
Molecular Formula: C15H21NO4
Molecular Weight: 279.332
Flash Point: 207.5±25.7 °C
Exact Mass: 279.147064
PSA: 66.84000
LogP: 3.61
Appearance of Characters: Powder | White to off-white
Vapour Pressure: 0.0±1.0 mmHg at 25°C
Index of Refraction: 1.529
Storage condition: Store at RT.
 
Specification
Appearance: White to off-white powder
Assay: ≥98.0%
 
Application
Amino Acid Derivatives. Be used as pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

N-Cbz-N-methyl-L-isoleucine


Related News: Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.Methyl 2-sulfamoylbenzoate CAS:57683-71-3 This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?2-Methylnaphthalene This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?3-amino-4-cyclobutyl-2-oxobutanamide,hydrochloride CAS:817169-86-1 From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances).The KCDC said a 28-year-old man had tested positive. He was among the 368 repatriated South Koreans who arrived from Wuhan on a charter flight on January 31. The rest of the evacuees have tested negative for the coronavirus.

Related Products
Product Name
2-Fluorobenzotrifluoride View Details
N-Benzyl-1-(4-methoxyphenyl)propan-2-amine View Details
1-Chlorohexadecane View Details
Rhodanine-3-acetic acid manufacturer 1-(3-Chloropropoxy)-4-fluorobenzene manufacturer 2-METHOXY-5-NITROBENZOTRIFLUORIDE manufacturer Acetic Acid 2-Chloroethyl Ester manufacturer 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile manufacturer